Search by Drug Name or NDC

    NDC 00002-7712-61 Humalog 200 [iU]/mL Details

    Humalog 200 [iU]/mL

    Humalog is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00002-7712
    Product ID 0002-7712_e57e8ab9-295b-4fb7-b723-e7b008117e9a
    Associated GPIs 2710400500D230
    GCN Sequence Number 073403
    GCN Sequence Number Description insulin lispro INSULN PEN 200/ML (3) SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 37798
    HICL Sequence Number 011528
    HICL Sequence Number Description INSULIN LISPRO
    Brand/Generic Brand
    Proprietary Name Humalog
    Proprietary Name Suffix KwikPen
    Non-Proprietary Name Insulin lispro
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 200
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN LISPRO
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA205747
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-7712-61 (00002771261)

    NDC Package Code 0002-7712-61
    Billing NDC 00002771261
    Package 1 SYRINGE in 1 CARTON (0002-7712-61) / 3 mL in 1 SYRINGE
    Marketing Start Date 2017-10-01
    NDC Exclude Flag N
    Pricing Information N/A